| |
| |
|
| Insider
Information: |
Nuechterlein Carole |
| Relationship: |
|
| City: |
Bannockburn |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,025,941 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,025,941 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avexis, Inc. |
AVXS |
|
|
0 |
|
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
|
|
0 |
|
0 |
Premium* |
|
|
Aligos Therapeutics, Inc. |
ALGS |
|
2020-10-20 |
0 |
2023-10-25 |
11,025,941 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
2 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALGS |
Aligos Therapeutics, Inc. |
|
• • • |
2023-10-25 |
4 |
B |
$0.76 |
$6,004,149 |
I/I |
7,933,601 |
11,025,941 |
0.01 |
- |
|
| ALGS |
Aligos Therapeutics, Inc. |
Director |
– • – |
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
3,092,340 |
3,092,340 |
0 |
- |
|
2 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
